Cognitive Functioning in Adolescents with Schizophrenia Treated with Paliperidone: Interim Data From a 6-Month, Open-Label Study

Wednesday, October 19, 2011

Gahan Pandina, Ph.D., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ

Timothy J. Petersen, Ph.D., Psychiatry, Massachusetts General Hospital, Topsfield, MA

Jaskaran Singh, M.D., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ

Ujjwala Vijapurkar, Ph.D., Psychiatry, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ

David Hough, M.D., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 1.34 Cognitive Functioning in Adolescents with Schizophrenia Treated with Paliperidone: Interim Data From a 6-Month, Open-Label Study